A significant discovery in cancer study is emerging with the use of VHH fragments to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in several forms of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research